• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Market Research Report > Pharmaceutical > Generic Drugs > Biosimilar Market Research Reports

Biosimilar Market Research Reports

We offer market research, industry forecasts, and business analysis in the Biosimilar as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis.

  • All (128)
  • Biosimilar (72)

Filter
Title Search
1 - 25 of 72 Products Sort by Display
Global Biosimilar Monoclonal Antibodies Sales Market Report 2018
Published by
QYResearch
Product code
668788
Published
July 31, 2018
Content info
170 Pages
Price
USD 4000
Sample available
Biosimilar Index: Tracking the Biosimilar Development Landscape
Published by
FirstWord
Product code
298599
Published
annual subscription
Content info
Database + 135 Slides
Price
USD 19000
Sample available
Biosimilars Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2016 - 2025
Published by
Variant Market Research LLP
Product code
629522
Published
April 16, 2018
Content info
102 Pages
Price
USD 3195
Sample available
Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, rHGH, Interferon), Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-house, Contract), Disease (Oncology, Autoimmune) - Global Forecast to 2023
Published by
MarketsandMarkets
Product code
290171
Published
April 6, 2018
Content info
183 Pages
Price
USD 5650
Sample available
Biosimilars: US Payer Perspectives (2018)
Published by
FirstWord
Product code
328749
Published
April 1, 2018
Content info
 
Price
USD 2495
Sample available
Biosimilars: Global Markets
Published by
BCC Research
Product code
242224
Published
March 28, 2018
Content info
340 Pages
Price
USD 3950
Sample available
Global Biosimilar Monoclonal Antibodies Forecast 2018-2028: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab
Published by
Visiongain Ltd
Product code
275993
Published
February 27, 2018
Content info
204 Pages
Price
USD 3644
Sample available
Biosimilars: EU Payer Perspectives
Published by
FirstWord
Product code
326352
Published
February 1, 2018
Content info
 
Price
USD 2495
Sample available
Biosimilar Insulin Market Access
Published by
Datamonitor Healthcare
Product code
498961
Published
January 26, 2018
Content info
19 Pages
Price
USD 5000
Sample available
Biosimilars Market Access in the EU
Published by
Datamonitor Healthcare
Product code
604015
Published
January 19, 2018
Content info
137 Pages
Price
USD 7500
Sample available
APAC Biosimilar Market, Forecast 2025
Published by
Frost & Sullivan
Product code
602441
Published
January 10, 2018
Content info
160 Pages
Price
USD 4950
Sample available
*
Published by
Kalorama Information
Product code
96359
Published
November 14, 2017
Content info
214 Pages
Price
USD 4500
Sample available
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - 2017 Update
Published by
La Merie Publishing
Product code
358307
Published
November 2, 2017
Content info
58 Pages
Price
USD 525
Sample available
*
Published by
Stratistics Market Research Consulting
Product code
599839
Published
November 1, 2017
Content info
167 Pages
Price
USD 4150
Sample available
*
Published by
FirstWord
Product code
581398
Published
November 1, 2017
Content info
 
Price
USD 2245
Sample available
Clinical Trial Strategies in Biosimilar Drug Development
Published by
Datamonitor Healthcare
Product code
573565
Published
October 13, 2017
Content info
149 Pages
Price
USD 10000
Sample available
*
Published by
MP Advisors
Product code
565345
Published
October 13, 2017
Content info
104 Pages
Price
USD 4000
Sample available
Oncology Biosimilars Market (Drug Class - G-CSF, Monoclonal Antibodies, and Hematopoietic Agents; Disease Indication; Distribution Channel) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025
Published by
Transparency Market Research
Product code
562204
Published
September 15, 2017
Content info
183 Pages
Price
USD 5795
Sample available
The Future of Biosimilars in the USA: Mapping critical uncertainties and the impact of future events
Published by
FirstWord
Product code
561558
Published
September 1, 2017
Content info
 
Price
USD 2245
Sample available
Japan Biosimilars - A start of Authorized Biosimilar Era?
Published by
MP Advisors
Product code
541442
Published
August 14, 2017
Content info
128 Pages
Price
USD 4000
Sample available
Biosimilars Real World Evidence: Proving the point
Published by
FirstWord
Product code
561547
Published
July 1, 2017
Content info
 
Price
USD 2245
Sample available
The Future of Biosimilars in Europe: Mapping critical uncertainties and the impact of future events
Published by
FirstWord
Product code
520365
Published
June 1, 2017
Content info
 
Price
USD 2245
Sample available
Global Biosimilars and Follow-On Biologics Market 2017-2027: Monoclonal Antibodies (mAbs), Fusion Proteins, Insulin, Erythropoietins, Granulocyte Colony-Stimulating Factor (G-CSF), Interferons, Growth Hormones, Fertility Hormones
Published by
Visiongain Ltd
Product code
204743
Published
May 2, 2017
Content info
318 Pages
Price
USD 3644
Sample available
Biosimilars in Emerging Markets
Published by
Datamonitor Healthcare
Product code
573567
Published
April 20, 2017
Content info
116 Pages
Price
USD 7500
Sample available
The Future of Biobetters
Published by
FirstWord
Product code
488073
Published
April 1, 2017
Content info
 
Price
USD 2245
Sample available